1 - Bill of Material for RFQ-NIAID-23-2174971.xlsx

XLSX spreadsheet 13 KB Posted

Attached to
Brand Name or Equal Roche Diagnostics Reagents
Solicitation number
RFQ-NIAID-23-2174971-1
Issued by

About this file

This document is a bill of material for a request for quote from the National Institutes of Health National Institute of Allergy and Infectious Diseases. It lists 22 items of reagents and kits from Roche Diagnostics required for clinical trials, including KAPA RNA HyperPrep kits, KAPA UDI Primer Mixes, KAPA HyperCapture kits, KAPA HiFi HS Lib Amp kits, and a KAPA Lib Quant kit. Quotes must be submitted in the exact order of the bill of material and are required to come from products compatible with Roche Diagnostic instruments, chemistry, and assays to ensure clinical trials continuity protocols. The shipping destination is Hamilton, Montana and country of origin is required for each line item. Equal products may be quoted if details demonstrating equivalency to the specified Roche Diagnostics products are included.

View the file

Other files

File Type Posted
4 - HHSAR 352.232-71.docx DOCX document
4 - HHSAR 352.docx DOCX document
4 - FAR 52.212-5 MARCH 2023.docx DOCX document
IPP collector-quick-reference-guide.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sheet1

RFQ-NIAID-23-2174971-1
Brand Name or equal
Roche Diagnostics Reagents
https://diagnostics.roche.com/us/en/products
#DescriptionCatalogQty
1KAPA RNA HyperPrep with RiboErase Globin (96 rxn)83082417023 each
2KAPA RNA HyperPrep (96 rxn)80981077021 each
3KAPA UDI Primer Mixes 1-9691343360011 each
4KAPA UDI Primer Mixes 97-19293298380011 each
5KAPA Adapter Dilution Buffer82785390011 each
6KAPA HyperCapture Bead Kit, 96 rxn90757980011 each
7KAPA HyperCapture Reagent Kit, 96 rxn90758280011 each
8KAPA Probes Resuspension Buffer, 1 ml90758790012 each
9KAPA Lib Quant Kit79601400011 each
10KAPA HiFi HS Lib Ampkit + primer (50 rxn)79589780012 each
11KAPA RNA HyperPrep (96rxn)80981077028 each
12KAPA Adapter Dilution Buffer82785390012 each
13KAPA Hybrid Enhancer Reagent, 1 ml90757630013 each
14KAPA HyperCapture Bead Kit, 96 rxn90757980016 each
15KAPA HyperCapture Reagent Kit, 96 rxn90758280016 each
13KAPA Probes Resuspension Buffer , 1 ml90758790013 each
17KAPA UDI Primer Mixes, 1-96 , 96 rxn91343360012 each
18KAPA UDI Primer Mixes, 97-192, 96 rxn93298380012 each
19KAPA UDI Primer Mixes, 193-288, 96 rxn93298460012 each
20KAPA UDI Primer Mixes, 289-384, 96 rxn93298540012 each
21KAPA HiFi HS Lib AmpKit+Primer (50rxn)795897800116 each
22Lib Quant Kit (Illumina/Uni)79601400014 each
23shipping
FOB Shipping destination: Hamilton, MT 59840
Country of Origin must be included for each line item on quote
Quotes for equal products must include details that demonstrate in detail being an equal product in order to be considered.
Quotes will be evaluated per FAR Part 25
Quote must list items in the exact order as this bill of material
Must be compatible withRoche Diagnostic Instruments, chemistry, and assay kits - per clinical trials continuity protocols.
52.211-6 Brand Name or Equal.

Brand Name or Equal (Aug 1999)

(a) If an item in this solicitation is identified as "brand name or equal," the purchase description reflects the characteristics and level of quality that will satisfy the Government’s needs. The salient physical, functional, or performance characteristics that "equal" products must meet are specified in the solicitation.

(b) To be considered for award, offers of "equal" products, including "equal" products of the brand name manufacturer, must-

(1) Meet the salient physical, functional, or performance characteristic specified in this solicitation;

(2) Clearly identify the item by-

(i) Brand name, if any; and

(ii) Make or model number;

(3) Include descriptive literature such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer; and

(4) Clearly describe any modifications the offeror plans to make in a product to make it conform to the solicitation requirements. Mark any descriptive material to clearly show the modifications.

(c) The Contracting Officer will evaluate "equal" products on the basis of information furnished by the offeror or identified in the offer and reasonably available to the Contracting Officer. The Contracting Officer is not responsible for locating or obtaining any information not identified in the offer.

(d) Unless the offeror clearly indicates in its offer that the product being offered is an "equal" product, the offeror shall provide the brand name product referenced in the solicitation.

(End of provision) https://diagnostics.roche.com/us/en/products

File details come from the government source that posted it. Updated .